| NDC Code | 51754-5060-1 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (51754-5060-1) / 5 mL in 1 VIAL, MULTI-DOSE |
|---|
| Product NDC | 51754-5060 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Betamethasone Sodium Phosphate And Betamethasone Acetate |
|---|
| Non-Proprietary Name | Betamethasone Sodium Phosphate And Betamethasone Acetate |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
|---|
| Start Marketing Date | 20210601 |
|---|
| Marketing Category Name | NDA AUTHORIZED GENERIC |
|---|
| Application Number | NDA014602 |
|---|
| Manufacturer | Exela Pharma Sciences, LLC |
|---|
| Substance Name | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
|---|
| Strength | 3; 3 |
|---|
| Strength Unit | mg/mL; mg/mL |
|---|
| Pharmacy Classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC] |
|---|